Digital Solutions in Heart Therapy (DIGNITY)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This study aims to assess the safety and effectiveness of telemedicine guided strategy on guideline-directed medical therapy (GDMT) optimization in hospitalized patients with heart failure in comparison to usual care in Switzerland.
Eligibility criteria
Qualifiers
Age > 18 years at the time of hospital admission
Ability to use a (smart)phone and/or tablet for the follow-up
Documented left ventricular ejection fraction (LVEF) > 40% assessed within preceding 12 months
Not treated with optimal doses of oral HF therapies within 2 days before anticipated hospital discharge for acute HF in at least one of the medication categories (for details see Table 1 on page 10)
Disqualifiers
Inability to use a (smart)phone or tablet
Clear intolerance to high doses of betablockers, ACE inhibitors, or ARBs
Estimated glomerular filtration rate <30ml/min/1.73m2 or dialysis
Myocardial infarction, unstable angina or cardiac surgery within 3 months, percutaneous transluminal coronary intervention within 1 months prior to screening
Trial design
Treatments tested in this trial
- usual care
- guideline-directed medical therapy
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov